我国消除疟疾后再输入风险评估研究进展

刘巧; 刘珏

doi:10.16462/j.cnki.zhjbkz.2024.01.014

我国消除疟疾后再输入风险评估研究进展

doi: 10.16462/j.cnki.zhjbkz.2024.01.014

刘巧,
刘珏^,

北京大学公共卫生学院流行病与卫生统计学系，北京 100191

基金项目:

国家自然科学基金 72122001

国家自然科学基金 72211540398

科技部对发展中国家科技援助 KY202101004

详细信息

通讯作者:
刘珏，E-mail: jueliu@bjmu.edu.cn

中图分类号: R183.5
计量
- 文章访问数: 107
- HTML全文浏览量: 49
- PDF下载量: 21
- 被引次数: 0
出版历程
- 收稿日期: 2022-07-29
- 修回日期: 2022-10-24
- 网络出版日期: 2024-02-05
- 刊出日期: 2024-01-10

Advances in risk assessment of importation after elimination of malaria in China

LIU Qiao,
LIU Jue^,

Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China

Funds:

National Natural Science Foundation of China 72122001

National Natural Science Foundation of China 72211540398

National Science and Technology Project on Development Assistance for Technology, Developing China-ASEAN Public Health Research and Development Collaborating Center KY202101004

More Information

Corresponding author: LIU Jue, E-mail: jueliu@bjmu.edu.cn

摘要

摘要: 中国于2021年被WHO认证成功消除疟疾，但仍面临境外疟疾的输入风险。现阶段中国疟疾防控应侧重预防输入和输入后再传播。本研究就目前中国防疟疾输入面临的主要问题，以及对已经建立的消除后阶段疟疾输入风险评估指标体系进行综述，为中国未来疟疾防控提出建议。
- 疟疾 /
- 输入风险 /
- 指标体系
Abstract: In 2021, China was recognized by the WHO as having successfully eliminated malaria, but is still at risk of importation of malaria from abroad. At present, malaria prevention and control in China should focus on prevention of importation and re-establishment. This paper reviewed the main issues of prevention of imported malaria that China faced and the established risk assessment index system for imported malaria, and made recommendations for future malaria prevention and control in China.
- Malaria /
- Risk of importation /
- Index system

HTML全文

参考文献(25)

[1]	World Health Organization. WHO fact sheets: malaria[EB/OL]. (2022-12-08)[2023-01-01]. https://www.who.int/news-room/fact-sheets/detail/malaria.
[2]	Zhang QQ, Liu Y, Hu YB, et al. The "1-3-7" approach to malaria surveillance and response - Henan Province, China, 2012-2018[J]. China CDC Wkly, 2020, 2(17): 289-292. DOI: 10.46234/ccdcw2020.074.
[3]	Andriopoulos P, Economopoulou A, Spanakos G, et al. A local outbreak of autochthonous Plasmodium vivax malaria in Laconia, Greece: a re-emerging infection in the southern borders of Europe?[J]. Int J Infect Dis, 2013, 17(2): e125-e128. DOI: 10.1016/j.ijid.2012.09.009.
[4]	Li ZJ, Yang YC, Xiao N, et al. Malaria imported from Ghana by returning gold miners, China, 2013[J]. Emerg Infect Dis, 2015, 21(5): 864-867. DOI: 10.3201/2105.141712.
[5]	Ericsson CD, Hatz C, Leder K, et al. Illness in travelers visiting friends and relatives: a review of the GeoSentinel surveillance network[J]. Clin Infect Dis, 2006, 43(9): 1185-1193. DOI: 10.1086/507893.
[6]	Fried M, Duffy PE. Malaria during pregnancy[J]. Cold Spring Harb Perspect Med, 2017, 7(6): a025551. DOI: 10.1101/cshperspect.a025551.
[7]	Arisco NJ, Peterka C, Castro MC. Cross-border malaria in northern Brazil[J]. Malar J, 2021, 20(1): 1-13. DOI: 10.1186/s12936-021-03668-4.
[8]	Wangdi K, Gatton ML, Kelly GC, et al. Cross-border malaria: a major obstacle for malaria elimination[J]. Adv Parasitol, 2015, 89: 79-107. DOI: 10.1016/bs.apar.2015.04.002.
[9]	Bousema T, Okell L, Felger I, et al. Asymptomatic malaria infections: detectability, transmissibility and public health relevance[J]. Nat Rev Microbiol, 2014, 12(12): 833-840. DOI: 10.1038/nrmicro3364.
[10]	Lee RA, Puig H, Nguyen PQ, et al. Ultrasensitive CRISPR-based diagnostic for field-applicable detection of Plasmodium species in symptomatic and asymptomatic malaria[J]. Proc Natl Acad Sci USA, 2020, 117(41): 25722-25731. DOI: 10.1073/pnas.2010196117.
[11]	Huang F, Takala-Harrison S, Liu H, et al. Prevalence of clinical and subclinical Plasmodium falciparum and Plasmodium vivax malaria in two remote rural communities on the Myanmar-China border[J]. Am J Trop Med Hyg, 2017, 97(5): 1524-1531. DOI: 10.4269/ajtmh.17-0167.
[12]	Baird JK. 8-aminoquinoline therapy for latent malaria[J]. Clin Microbiol Rev, 2019, 32(4): e00011-e00019. DOI: 10.1128/CMR.00011-19.
[13]	Marteau A, Ouedraogo E, ven der Meersch G, et al. Severe long-delayed malaria caused by plasmodium malariae in an elderly French patient[J]. Malar J, 2021, 20(1): 337. DOI: 10.1186/s12936-021-03870-4.
[14]	ven der Berg H. Global status of DDT and its alternatives for use in vector control to prevent disease[J]. Environ Health Perspect, 2009, 117(11): 1656-1663. DOI: 10.1289/ehp.0900785.
[15]	Adjuik M, Babiker A, Garner P, et al. Artesunate combinations for treatment of malaria: meta-analysis[J]. Lancet, 2004, 363(9402): 9-17. DOI: 10.1016/s0140-6736(03)15162-8.
[16]	Balikagala B, Fukuda N, Ikeda M, et al. Evidence of artemisinin-resistant malaria in Africa[J]. N Engl J Med, 2021, 385(13): 1163-1171. DOI: 10.1056/NEJMoa2101746.
[17]	Ashley EA, Phyo AP, Woodrow CJ. Malaria[J]. Lancet, 2018, 391(10130): 1608-1621. DOI: 10.1016/S0140-6736(18)30324-6.
[18]	Gefen-Halevi S, Belinson V, Manor U, et al. HRP2/3 mutation in recrudescent Plasmodium falciparum malaria case acquired in Ethiopia[J]. J Travel Med, 2021, 28(5): taaa196. DOI: 10.1093/jtm/taaa196.
[19]	Yin J, Yan H, Li M. Prompt and precise identification of various sources of infection in response to the prevention of malaria re-establishment in China[J]. Infect Dis Poverty, 2022, 11(1): 45. DOI: 10.1186/s40249-022-00968-y.
[20]	Dong Y, Liu SP, Deng Y, et al. Genetic polymorphism of histidine rich protein 2 in plasmodium falciparum isolates from different infection sources in Yunnan Province, China[J]. Malar J, 2019, 18(1): 446. DOI: 10.1186/s12936-019-3084-4.
[21]	陈田木, 张少森, 周水森. 疟疾再传播风险评估方法与指标参数的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2017, 35(5): 489-494. Chen TM, Zhang SS, Zhou SS. Progress in research on risk assessment approach and parameters for malaria re-emergence[J]. Chin J Parasitol Parasit Dis, 2017, 35(5): 489-494.
[22]	兰子尧, 李杨, 黄雨婷, 等. 输入性疟疾再传播风险评估指标体系的构建[J]. 中国血吸虫病防治杂志, 2022, 34(2): 163-171. DOI: 10.16250/j.32.1374.2022023. Lan ZY, Li Y, Huang YT, et al. Construction of risk assessment index system for re-transmission of imported malaria[J]. Chin J Schistosomiasis Control, 2022, 34(2): 163-171. DOI: 10.16250/j.32.1374.2022023.
[23]	Lei L, Richards JS, Li ZH, et al. A framework for assessing local transmission risk of imported malaria cases[J]. Infect Dis Poverty, 2019, 8(1): 43. DOI: 10.1186/s40249-019-0552-6.
[24]	莫晓彤, 夏尚, 艾琳, 等. 在消除阶段我国疟疾风险评估指标体系研究[J]. 中国热带医学, 2021, 21(6): 505-511. DOI: 10.13604/j.cnki.46-1064/r.2021.06.02. Mo XT, Xia S, Ai L, et al. Study on a framework for risk assessment of imported malaria in China during malaria elimination[J]. China Trop Med, 2021, 21(6): 505-511. DOI: 10.13604/j.cnki.46-1064/r.2021.06.02.
[25]	陈田木. 疟疾再传播风险评估指标体系及模型研究[D]. 北京: 中国疾病预防控制中心, 2018. Chen TM. Study on risk assessment index system and model of malaria re-transmission[D]. Beijing: Chinese Center for Diseases Control and Prevention, 2018.